Trinity Biotech plc Sponsored ADR (TRIB)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Trinity Biotech's Redesigned CGM Sensor Favored by New Clinical Data
TRIB's needle-free CGM+ sensor shows accurate 15-day results with no calibration, slashing costs and boosting access.
Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript
Trinity Biotech Plc (NASDAQ:TRIB ) Q3 2024 Earnings Conference Call November 15, 2024 10:00 AM ET Company Participants Eric Ribner - Investor Relations John Gillard – President, Chief Executive Officer Louise Tallon - Chief Financial Officer Conference Call Participants James Sidoti - Sidoti & Company Paul Nouri – Noble Equity Funds Operator Greetings. Welcome to the Trinity Biotech Third Quarter 2024 Earnings Conference Call.
Trinity Biotech Shares Surge on Positive Pre-Pivotal Clinical CGM Trial
TRIB announces positive results from its pre-pivotal clinical European trial for a next-gen continuous glucose monitor, setting the stage for further development in 2025.
Trinity Biotech's Stock Rises After Acquisition of Metabolomics
TRIB acquires Metabolomics Diagnostics, expanding its platform with cutting-edge tech to enhance diagnostics in maternal health and diabetes management.
Will Trinity Biotech Stock Gain From Its Latest Patent Process?
TRIB announces updates on its European patented process. The company aims to use this process to improve the functionality of its glucose biosensor in its next-gen CGM technology.
Trinity Biotech plc (TRIB) Q2 2024 Earnings Call Transcript
Trinity Biotech plc (NASDAQ:TRIB ) Q2 2024 Earnings Conference Call August 14, 2024 8:30 AM ET Company Participants Eric Ribner - Investor Relations John Gillard - Chief Executive Officer Simon Dunne - Chief Accounting Officer Conference Call Participants Jim Sidoti - Sidoti & Company Andrew Mei - Private Investor Operator Welcome to the Trinity Biotech Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Trinity Biotech plc (TRIB) Q1 2024 Earnings Call Transcript
Trinity Biotech plc (NASDAQ:TRIB ) Q1 2024 Results Conference Call May 23, 2024 8:30 AM ET Company Participants Eric Ribner - Investor Relations John Gillard - Chief Executive Officer Des Fitzgerald - Chief Financial Officer Conference Call Participants Jim Sidoti - Sidoti & Company Operator Greetings, and welcome to the Trinity Biotech First Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
